Egbert Madamba

1.6k citations
28 papers · 849 indexed · 2 hit papers · h-index 13

Impact in

  • Hepatology top 2%
    • Liver Disease and Transplantation
    • Liver Diseases and Immunity
    • Liver Disease Diagnosis and Treatment

Papers in

    • Liver Disease and Transplantation 10
    • Liver Diseases and Immunity 7
    • Hepatocellular Carcinoma Treatment and Prognosis 5
    • Liver Disease Diagnosis and Treatment 27

Egbert Madamba

25 papers receiving 839 citations

Hit Papers

A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes 2022 · 162 citations
162202020262022202450100150200

Peers

Egbert Madamba
Comparison fields: 5 of 64
  • Hepatology 307
  • Epidemiology 717
  • Endocrinology, Diabetes and Metabolism 243
  • Physiology 142
  • Pathology and Forensic Medicine 80
Replace Angelo Armandi with:
Angelo Armandi Italy
Suzanne R. Sharpton United States
Junzhao Ye China
Somaya Albhaisi United States
Xinrong Zhang China
Shirin Bassirian United States
Sam Trinh United States
Emily Rizo United States
Consuelo Cefalo Italy
Osman Özdoğan Türkiye
Egbert Madamba relative to Angelo Armandi Italy Angelo Armandi's profile →
Citations per field
00.5×1.6×
Angelo Armandi · 1×
Citations per year

Countries citing papers authored by Egbert Madamba

Since Specialization
Citations

This map shows the geographic impact of Egbert Madamba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Egbert Madamba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Egbert Madamba more than expected).

Fields of papers citing papers by Egbert Madamba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Egbert Madamba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Egbert Madamba. The network helps show where Egbert Madamba may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Egbert Madamba, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Egbert Madamba Line = papers co-authored together Egbert Madamba links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20252
2 20256
3 20251
4 202511
5 202412
6 20243
7 202426
8 20236
9 20238
10 20230
11 20239
12 202313
13 202268
14 202222
15
A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes
Hit paper breakdown →
2022162
16 20227
17 202123
18 202053
19 202099
20
A Universal Gut-Microbiome-Derived Signature Predicts Cirrhosis
Hit paper breakdown →
2020240

About Egbert Madamba

Egbert Madamba is a scholar working on Hepatology, Epidemiology, Pathology and Forensic Medicine, Endocrinology, Diabetes and Metabolism and Rheumatology, having authored 28 papers that have together received 849 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (27 papers), Liver Disease and Transplantation (10 papers), Liver Diseases and Immunity (7 papers), Alcohol Consumption and Health Effects (7 papers), Diet, Metabolism, and Disease (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Folate and B Vitamins Research (3 papers) and Pancreatitis Pathology and Treatment (3 papers). The work is most often cited by research in Hepatology (307 citations), Epidemiology (717 citations), Endocrinology, Diabetes and Metabolism (243 citations), Physiology (142 citations) and Pathology and Forensic Medicine (80 citations). Egbert Madamba has collaborated with scholars based in United States, Singapore and Japan. Frequent co-authors include Ricki Bettencourt, Lisa Richards, Claude B. Sirlin, Rohit Loomba, Veeral Ajmera, Seema Singh, Scarlett Lopez, Jinho Jung, Ruth T. Yu and Annette R. Atkins. Their work appears in journals such as Alimentary Pharmacology & Therapeutics, Journal of Hepatology, Gut, Cell Metabolism and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026